Helen Tesfaye, PharmD, MSc

Research Specialist
Division of Pharmacoepidemiology, Dept. of Medicine, Brigham & Women’s Hospital, Harvard Medical School

Poster(s):

• (149) Effects of demographics on outcomes with empagliflozin vs. DPP4i
  Wednesday, October 29, 2025